Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
140 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
15 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 16, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 10, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 10, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 10, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 18, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Dec 18, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 18, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Dec 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 16, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Nov 27, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom assembling of materials for others; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; custom production of biological preparations; processing of biomedical preparations; processing of biotechnology drug; processing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals;
Class 042
Consulting services in the field of technology development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biomedical research services;
First Use Anywhere:
Oct 29, 2024
First Use in Commerce:
Oct 29, 2024
Additional Information
Design Mark
The mark consists of the stylized wording "WuXia RidGS" with a line with slanted ends appearing under the wording "WuXia". The "X" in "WuXia" extends down and covers the line. Beginning above the "i" in the wording "RidGS", an arched tapered line extends upward to the right. A small perpendicular line cross the arched line above the "i".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RID GS"